register

News & Trends - Pharmaceuticals

Organon ANZ founder and MD to depart for new opportunity

Health Industry Hub | June 11, 2024 |

Pharma News: Organon ANZ has announced the departure of Managing Director Nirelle Tolstoshev, effective June 28, as she embarks on a new opportunity outside the organisation. This announcement follows the promotion of several ANZ founders to key APAC roles at the end of May.

Organon, the first major global pharmaceutical company dedicated to women’s health, was spun off from MSD and listed on the New York Stock Exchange in 2021, with Tolstoshev at the helm of the Australian team. Prior to leading Organon ANZ, Tolstoshev spent 21 years at MSD, starting as a medical representative in Adelaide and advancing through various sales, marketing, and business unit management roles.

“Nirelle is known for her passion, personal ‘People First’ approach in managing an incredibly dynamic team, as well as for her innovative thinking to support our founders and the business to grow,” said Andreas Daugaard Jørgensen, Managing Director, Asia Pacific.

Around 34% of CEO and Head of Organisation roles in the biopharmaceutical sector are held by women – and whilst women tend to be well represented in middle management, they seem to be passed over for more senior opportunities.

Tolstoshev has consistently demonstrated her commitment to fostering female talent and has empowered women through initiatives like the Franklin Women’s Members Connect Series.

“Nirelle has an incredible reputation as an authentic and highly skilled business leader with deep expertise in the healthcare environment. She is recognised as a champion for women in science. I am proud that Nirelle’s growth and experience at Organon has led to new opportunities for her, while she was building a strong foundation for the continued growth and impact of Organon in Australia and New Zealand,” Daugaard Jørgensen added.

Organon will commence the search for a new lead for its operations in Australia and New Zealand.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Clinicians unveil Novartis and BMS practice-changing trial results

Clinicians unveil Novartis and BMS practice-changing trial results

Health Industry Hub | June 24, 2024 |

Pharma News: Australia, known for its alarming melanoma rates, witnesses one person diagnosed with the disease every 30 minutes, and […]

More


News & Trends - Pharmaceuticals

Hearts4heart leads awareness week, amid progress in Boehringer Ingelheim and AstraZeneca therapies

Hearts4heart leads awareness week, amid progress in Boehringer Ingelheim and AstraZeneca therapies

Health Industry Hub | June 24, 2024 |

Pharma News: Heart failure is a significant health concern in Australia, affecting approximately half a million people, with over 67,000 […]

More


News & Trends - MedTech & Diagnostics

Cardiologists mark Australian first with Boston Scientific's intracoronary imaging system

Cardiologists mark Australian first with Boston Scientific’s intracoronary imaging system

Health Industry Hub | June 24, 2024 |

MedTech & Diagnostics News: Percutaneous coronary intervention (PCI) has faced substantial complications and failure rates, despite advances in medical devices […]

More


Leadership & Management

AbbVie New Zealand welcomes new leadership amid global moves

AbbVie New Zealand welcomes new leadership amid global moves

Health Industry Hub | June 24, 2024 |

Leadership & Management: In line with its global talent development plan, AbbVie has announced a significant change in leadership for […]

More


This content is copyright protected. Please subscribe to gain access.